In the yeast Saccharomyces cerevisiae, there are two homologs of mammalian ras genes, RASI and RAS2 (7,26), which appear to be potent activators of adenylate cyclase (39). In mammalian cells, however, neither the target nor the regulator of the ras proteins is understood. S. cerevisiae is potentially a good experimental system for understanding ras function. First, like the mammalian ras proteins, the yeast RAS proteins are capable of binding and hydrolyzing guanine nucleotides (9, 36). Second, yeast cells carrying the RAS2VaI-l9 mutation, analogous to the oncogenic variation in human H-rasval12, do not arrest properly at Gl in response to nutrient limitation (16). Finally, human H-ras protein is also a potent activator of yeast adenylate cyclase (3), although the ultimate target of ras may not be an adenylate cyclase in mammalian cells (1). These structural and biochemical homologies between mammalian and yeast ras proteins suggest that the identification of molecules interacting with RAS proteins in S. cerevisiae may facilitate the understanding of the function of mammalian ras proteins. Recently, it was shown that the CDC25 gene product is essential for activation of adenylate cyclase in S. cerevisiae (4,27). From biochemical experiments, Broek et al. (4) proposed that the CDC25 protein may regulate adenylate cyclase by regulating the guanine nucleotide bound to RAS proteins.In S. cerevisiae, cyclic AMP (cAMP) has a crucial role in cell cycle progression via activation of the cAMP-dependent protein kinase (A kinase). cAMP produced by adenylate cyclase encoded by the CYR] (15) gene binds to the kinase regulatory subunit, encoded by the BCYJ (37, 42) gene, to release catalytic subunits encoded by the TPKI, TPK2, and TPK3 genes (38). Free catalytic subunits then phosphorylate unknown target protein(s) whose phosphorylation is essential for cell cycle progression. Mutations that block activation of A kinase, such as cyrl, cdc25, or rasi ras2, prevent entry into the mitotic cycle, whereas mutations that cause high, constitutive levels of cAMP-dependent protein phos-* Corresponding author. phorylation, such as bcyl, ppdl, or RAS2va l9, interfere with sporulation and entry into the resting state. The ppdl mutant has been reported to be deficient in the dephosphorylation of the putative target proteins for A kinase (for a review, see reference 21; 22).Here we further characterized the PPDJ gene at the molecular level. In contrast to the previous report, we found no significant difference in protein phosphatase activity between a wild-type strain and an isogenic strain in which the PPDI gene was disrupted. Moreover, our results suggest that the PPDJ protein regulates the RAS-cAMP pathway. Thus, we introduce the name "IRAI" (inhibitory regulator of the RAS-cAMP pathway) to replace "PPDJI". In contrast to the function of the CDC25 protein, the IRA] protein is required for keeping cAMP at a low level in response to nutritional limitation.
MATERIALS AND METHODSStrains, transformations, and culture media. Yeast strains use...